Can fasting or quitting smoking rewind your biological clock?
NCT ID NCT05678426
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether intermittent fasting or quitting smoking can change DNA markers linked to aging and cancer risk. 156 healthy women aged 30-60 followed a 6-month program with coaching and optional exercise. Researchers measured changes in DNA methylation patterns to see if these lifestyle shifts could lower disease risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
156 people
The number who actually took part.
- Started
-
Apr 2021
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 60 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Women aged 30 to 60 2. Motivated to change their lifestyle Smoking cessation intervention: 3a. Smoking cessation: ≥10 cigarettes per day for at least the last five years Dietary intervention: 3b Dietary intervention: BMI between 25 and 35 NB \[Nota Bene\], should 3a and 3b apply, participant will be allocated to the smoking cessation intervention. Exclusion Criteria: 1. Relevant underlying conditions: 1. Current or previous malignant tumour or cancer 2. Current or previous significant cardiovascular disorder \[participants with elevated blood pressure are allowed to participate as long as it is well controlled under their current medication\] 3. Current or previous metabolic disorder (e.g., diabetes type I or II) \[in the dietary intervention arm, participants with current hypothyroidism/Morbus Hashimoto will be excluded as the switch to intermittent fasting may require a adjustment of their medication\] 4. Current or previous psychiatric disorder (e.g., eating disorder, depression) 2. Current pregnancy or lactation period 3. Total hysterectomy 4. Known current or previous premalignant lesion of the cervix uteri (CIN2/3) 5. Concurrent participation in another interventional trial
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
European Translational Oncology Prevention and Screening Institute
Hall in Tirol, Tyrol, 6060, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Texts and wearables team up to help latinos quit smoking and get moving
- Can a protein powder with creatine and fiber boost everyday Well-Being?
- Green tech or hidden stress? bus Drivers' hearts monitored behind the wheel
- Can an AI chatbot help cancer patients kick the habit?
- Does the clock matter? scientists randomize when Quit-Smoking chatbots ping you
- Shout it out: can growls and screams raise pain tolerance?